Thrombogenicity of foreign surfaces is the major obstacle in cardiovascular interventions. Despite enormous advances in biomaterials research, the hemocompatibility of blood-contacting materials is still not satisfactory and the native endothelium still represents the ideal surface for blood contact. Circulating adult endothelial progenitor cells (EPCs) in the human blood provide an excellent source of autologous stem cells for the in vivo self-endothelialization of blood-contacting materials. For this purpose, material surfaces can be coated with capture molecules mimicking natural homing factors to attract circulating EPCs. Hitherto, several ligands, such as aptamers, monoclonal antibodies, peptides, selectins and their ligands, or magnetic molecules, are used to biofunctionalize surfaces for the capturing of EPCs directly from patient's bloodstream onto blood-contacting materials. Subsequently, attracted EPCs can differentiate into endothelial cells and generate an autologous endothelium. The in vivo self-endothelialization of blood-contacting materials prevents the recognition of them as a foreign body; this opens up revolutionary new prospects for future clinical stem-cell and tissue engineering strategies.

1.
Wendel HP, Ziemer G: Coating techniques to improve the hemocompatibility of artificial devices used for extracorporeal circulation. Eur J Cardiothorac Surg 1999;16:342-350.
[PubMed]
2.
Li S, Henry JJ: Nonthrombogenic approaches to cardiovascular bioengineering. Annu Rev Biomed Eng 2011;13:451-475.
[PubMed]
3.
Hoffmann J, et al: Immobilized DNA aptamers used as potent attractors for porcine endothelial precursor cells. J Biomed Mater Res A 2008;84:614-621.
[PubMed]
4.
Klomp M, Beijk MA, de Winter RJ: Genous endothelial progenitor cell-capturing stent system: a novel stent technology. Expert Rev Med Devices 2009;6:365-375.
[PubMed]
5.
Aoki J, Serruys PW, van Beusekom H, Ong AT, McFadden EP, Sianos G, van der Giessen WJ, Regar E, de Feyter PJ, Davis HR, Rowland S, Kutryk MJ: Endothelial progenitor cell capture by stents coated with antibody against CD34: the HEALING-FIM (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth-First In Man) Registry. J Am Coll Cardiol 2005;45:1574-1579.
[PubMed]
6.
Beijk MA, Klomp M, van GN, Koch KT, Henriques JP, Baan J, Vis MM, Tijssen JG, Piek JJ, de Winter RJ: Two-year follow-up of the Genous endothelial progenitor cell capturing stent versus the Taxus Liberte stent in patients with de novo coronary artery lesions with a high risk of restenosis: a randomized, single-center, pilot study. Catheter Cardiovasc Interv 2011;78:189-195.
[PubMed]
7.
Duckers HJ, et al: Accelerated vascular repair following percutaneous coronary intervention by capture of endothelial progenitor cells promotes regression of neointimal growth at long-term follow-up: final results of the HEALING II trial using an endothelial progenitor cell capturing stent (Genous R stent). Euro Intervention 2007;3:350-358.
[PubMed]
8.
Silber S, et al: Clinical results after coronary stenting with the Genous Bio-engineered R stent: 12-month outcomes of the e-HEALING (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth) worldwide registry. EuroIntervention 2011;6:819-825.
[PubMed]
9.
Rotmans JI, Heyligers JM, Verhagen HJ, Velema E, Nagtegaal MM, de Kleijn DP, de Groot FG, Stroes ES, Pasterkamp G: In vivo cell seeding with anti-CD34 antibodies successfully accelerates endothelialization but stimulates intimal hyperplasia in porcine arteriovenous expanded polytetrafluoroethylene grafts. Circulation 2005;112:12-18.
[PubMed]
10.
Peichev M, et al: Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 2000;95:952-958.
[PubMed]
11.
Klomp M, et al: 1-year outcome of TRIAS HR (TRI-stent adjudication study-high risk of restenosis) a multicenter, randomized trial comparing Genous endothelial progenitor cell capturing stents with drug-eluting stents. JACC Cardiovasc Interv 2011;4:896-904.
[PubMed]
12.
Granada JF, et al: Development of a novel prohealing stent designed to deliver sirolimus from a biodegradable abluminal matrix. Circ Cardiovasc Interv 2003;3:257-266.
[PubMed]
13.
Markway BD, McCarty OJ, Marzec UM, Courtman DW, Hanson SR, Hinds MT: Capture of flowing endothelial cells using surface-immobilized anti-kinase insert domain receptor antibody. Tissue Eng Part C Methods 2008;14:97-105.
[PubMed]
14.
Plouffe BD, Kniazeva T, Mayer JE Jr, Murthy SK, Sales VL: Development of microfluidics as endothelial progenitor cell capture technology for cardiovascular tissue engineering and diagnostic medicine. FASEB J 2009;23:3309-3314.
[PubMed]
15.
Langer HF, et al: Capture of endothelial progenitor cells by a bispecific protein/monoclonal antibody molecule induces reendothelialization of vascular lesions. J Mol Med 2010;88:687-699.
[PubMed]
16.
Hristov M, Erl W, Weber PC: Endothelial progenitor cells: mobilization, differentiation, and homing. Arterioscler Thromb Vasc Biol 2003;23:1185-1189.
[PubMed]
17.
Lim WH, et al: Stent coated with antibody against vascular endothelial-cadherin captures endothelial progenitor cells, accelerates re-endothelialization, and reduces neointimal formation. Arterioscler Thromb Vasc Biol 2011;31:2798-2805.
[PubMed]
18.
Lee JM, et al: Comparison of endothelialization and neointimal formation with stents coated with antibodies against CD34 and vascular endothelial-cadherin. Biomaterials 2012;33:8917-8927.
[PubMed]
19.
Blindt R, et al: A novel drug-eluting stent coated with an integrin-binding cyclic Arg-Gly-Asp peptide inhibits neointimal hyperplasia by recruiting endothelial progenitor cells. J Am Coll Cardiol 2006;47:1786-1795.
[PubMed]
20.
Joner M, Cheng Q, Schonhofer-Merl S, Lopez M, Neubauer S, Mas-Moruno C, Laufer B, Kolodgie FD, Kessler H, Virmani R: Polymer-free immobilization of a cyclic RGD peptide on a Nitinol stent promotes integrin-dependent endothelial coverage of strut surfaces. J Biomed Mater Res B Appl Biomater 2012;100:637-645.
[PubMed]
21.
Taite LJ, Yang P, Jun HW, West JL: Nitric oxide-releasing polyurethane-PEG copolymer containing the YIGSR peptide promotes endothelialization with decreased platelet adhesion. J Biomed Mater Res B Appl Biomater 2008;84:108-116.
[PubMed]
22.
Kushwaha M, Anderson JM, Bosworth CA, Andukuri A, Minor WP, Lancaster JR Jr, Anderson PG, Brott BC, Jun HW: A nitric oxide releasing, self-assembled peptide amphiphile matrix that mimics native endothelium for coating implantable cardiovascular devices. Biomaterials 2010;31;1502-1508.
[PubMed]
23.
Veleva AN, Heath DE, Cooper SL, Patterson C: Selective endothelial cell attachment to peptide-modified terpolymers. Biomaterials 2008;29:3656-3661.
[PubMed]
24.
Suuronen EJ, Zhang P, Kuraitis D, Cao X, Melhuish A, McKee D, Li F, Mesana TG, Veinot JP, Ruel M: An acellular matrix-bound ligand enhances the mobilization, recruitment and therapeutic effects of circulating progenitor cells in a hindlimb ischemia model. FASEB J 2009;23:1447-1458.
[PubMed]
25.
Narasipura SD, Wojciechowski JC, Charles N, Liesveld JL, King MR: P-selectin-coated microtube for enrichment of CD34+ hematopoietic stem and progenitor cells from human bone marrow. Clin Chem 2008;54:77-85.
[PubMed]
26.
Wojciechowski JC, Narasipura SD, Charles N, Mickelsen D, Rana K, Blair ML, King MR: Capture and enrichment of CD34-positive haematopoietic stem and progenitor cells from blood circulation using P-selectin in an implantable device. Br J Haematol 2008;140:673-681.
[PubMed]
27.
Pislaru SV, Harbuzariu A, Gulati R, Witt T, Sandhu NP, Simari RD, Sandhu GS: Magnetically targeted endothelial cell localization in stented vessels. J Am Coll Cardiol 2006;48:1839-1845.
[PubMed]
28.
Kyrtatos PG, Lehtolainen P, Junemann-Ramirez M, Garcia-Prieto A, Price AN, Martin JF, Gadian DG, Pankhurst QA, Lythgoe MF: Magnetic tagging increases delivery of circulating progenitors in vascular injury. JACC. Cardiovasc Interv 2009;2:794-802.
[PubMed]
29.
Yang JX, Tang WL, Wang XX: Superparamagnetic iron oxide nanoparticles may affect endothelial progenitor cell migration ability and adhesion capacity. Cytotherapy 2010;12:251-259.
[PubMed]
You do not currently have access to this content.